Reason for request
Assessment of change of dose permitting use in children aged between 2 and 16.
Clinical Benefit
| Substantial |
The clinical benefit provided by DUROGESIC in children is substantial. |
Clinical Added Value
| Comments without ASMR value |
DUROGESIC has previously been recognised by the Transparency Committee as providing actual benefit in adults, and it provides the same benefit for children over 2. |
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
BGF2dcUmQSXtQV9R
